SGMO — Sangamo Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Sangamo Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	377	278	81	41.9	20.9
Net Total Accounts Receivable
Net Total Receivables	6.36	4.47	1.33	4.6	10.5
Prepaid Expenses
Total Current Assets	399	300	94.3	51.7	35.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	125	126	52.9	34.8	14.1
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	722	563	165	102	59.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	128	112	47.7	45.8	42.5
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	347	268	82.4	78.9	74
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	375	295	82.9	22.8	-14.3
Total Liabilities & Shareholders' Equity	722	563	165	102	59.7
Total Common Shares Outstanding